Esra Sağlam

569 total citations
73 papers, 400 citations indexed

About

Esra Sağlam is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Esra Sağlam has authored 73 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 15 papers in Surgery. Recurrent topics in Esra Sağlam's work include Colorectal Cancer Surgical Treatments (10 papers), Colorectal and Anal Carcinomas (7 papers) and Gastric Cancer Management and Outcomes (7 papers). Esra Sağlam is often cited by papers focused on Colorectal Cancer Surgical Treatments (10 papers), Colorectal and Anal Carcinomas (7 papers) and Gastric Cancer Management and Outcomes (7 papers). Esra Sağlam collaborates with scholars based in Türkiye, United States and Serbia. Esra Sağlam's co-authors include Tayfun Uzbay, Hakan Kayır, Yasin Eren, Turgay Çelik, Dilek Akyıl, Muhsin Konuk, Emre Balık, Ethem Nezih Oral, Erhan Ayşan and Ufuk Oğuz İdiz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Esra Sağlam

66 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esra Sağlam Türkiye 11 139 84 84 65 53 73 400
Juan Wu China 13 74 0.5× 68 0.8× 143 1.7× 104 1.6× 39 0.7× 42 476
Bo Yuan China 12 93 0.7× 81 1.0× 117 1.4× 130 2.0× 53 1.0× 61 525
Jinxiu Chen China 13 58 0.4× 123 1.5× 44 0.5× 106 1.6× 55 1.0× 34 515
Y Uchida Japan 15 70 0.5× 63 0.8× 112 1.3× 136 2.1× 86 1.6× 48 594
Shujuan Zhang China 12 60 0.4× 82 1.0× 58 0.7× 86 1.3× 21 0.4× 35 390
Timothy M. Moore United States 14 104 0.7× 54 0.6× 92 1.1× 251 3.9× 49 0.9× 22 609
John J. Jones United States 9 73 0.5× 35 0.4× 83 1.0× 191 2.9× 77 1.5× 14 672
Chuan Shao China 14 45 0.3× 70 0.8× 41 0.5× 82 1.3× 44 0.8× 27 440

Countries citing papers authored by Esra Sağlam

Since Specialization
Citations

This map shows the geographic impact of Esra Sağlam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esra Sağlam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esra Sağlam more than expected).

Fields of papers citing papers by Esra Sağlam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esra Sağlam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esra Sağlam. The network helps show where Esra Sağlam may publish in the future.

Co-authorship network of co-authors of Esra Sağlam

This figure shows the co-authorship network connecting the top 25 collaborators of Esra Sağlam. A scholar is included among the top collaborators of Esra Sağlam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esra Sağlam. Esra Sağlam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sağlam, Esra, Pervin Hürmüz, Didem Çolpan Öksüz, et al.. (2025). The impact of malnutrition in the radiotherapy pathway in geriatric patients in the onco-surgical settings on behalf of the Turkish Society for Radiation Oncology Study Group (TROD 12-04). European Journal of Surgical Oncology. 51(8). 110057–110057.
2.
Görken, İlknur Bilkay, Didem Çolpan Öksüz, Birsen Yücel, et al.. (2024). Who would be the winner? A prognostic nomogram for predicting the benefit of postoperative radiotherapy ± chemotherapy in patients with locally advanced gastric cancer: TROD-02-01 study. Asian Journal of Surgery. 47(7). 3056–3062.
3.
Jazieh, Abdul Rahman, et al.. (2022). Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa – KINDLE Study. Clinical Lung Cancer. 23(4). 364–373. 4 indexed citations
4.
Sağlam, Esra, et al.. (2022). Anti-proliferative effects of paroxetine alone or in combination with sorafenib in HepG2 cells. Brazilian Journal of Pharmaceutical Sciences. 58. 3 indexed citations
5.
Sağlam, Esra, et al.. (2022). A dosimetric comparison for SBRT plans of localized prostate cancer between Cyberknife and Varian Truebeam STX device. Applied Radiation and Isotopes. 192. 110617–110617.
6.
Toker, Alper, Berker Özkan, Erkan Kaba, et al.. (2021). Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center. Turkish Journal of Thoracic and Cardiovascular Surgery. 29(4). 487–495. 1 indexed citations
7.
Şanlı, Yasemin, et al.. (2020). The Impact of Primary Tumor and Locoregional Metastatic Lymph Node SUV<sub>max</sub> on Predicting Survival in Patients with Rectal Cancer. Molecular Imaging and Radionuclide Therapy. 29(2). 65–71. 3 indexed citations
8.
Sağlam, Esra, et al.. (2020). Öteki Mekânlarda Sosyal Sorunlar: Bir Literatür Taraması. Opus uluslararası toplum araştırmaları dergisi. 16(29). 1–1. 1 indexed citations
11.
Sağlam, Sezer, Esra Sağlam, Pınar Fırat, et al.. (2018). Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment. Pathology - Research and Practice. 214(9). 1291–1296. 1 indexed citations
12.
Şentürk, Özgür, et al.. (2018). Yoğun Bakıma Yatırılan Zehirlenme Olgularının Değerlendirilmesi. SHILAP Revista de lepidopterología. 9(35). 109–113.
13.
Akyıl, Dilek, Muhsin Konuk, Yasin Eren, Recep Liman, & Esra Sağlam. (2017). Mutagenic and genotoxic effects of Anilofos with micronucleus, chromosome aberrations, sister chromatid exchanges and Ames test. Cytotechnology. 69(6). 865–874. 9 indexed citations
14.
Sağlam, Sezer, Esra Sağlam, Fatih Tunca, et al.. (2013). Neoadjuvant hyperfractionated-accelerated radiotherapy with concomitant chemotherapy in esophageal cancer: phase II study.. Istanbul Science University (Istanbul Bilim University). 2 indexed citations
15.
Küçükhüseyin, Özlem, et al.. (2013). Do CDKN2 p16 540 C>G , CDKN2 p16 580 C>T , and MDM2 SNP309 T>G Gene Variants Act on Colorectal Cancer Development or Progression?. DNA and Cell Biology. 32(7). 400–408. 11 indexed citations
16.
Şen, Fatma, Esra Sağlam, Alper Toker, et al.. (2011). Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 68(6). 1497–1505. 3 indexed citations
17.
18.
Sağlam, Esra, et al.. (2007). Effects of olanzapine on ethanol withdrawal syndrome in rats. European Journal of Pharmacology. 579(1-3). 208–214. 14 indexed citations
19.
Oğuz, Hilal, Hakan Çamlıca, Derya Duranyıldız, et al.. (2006). Matriks metalloproteinazlar ve akciğer kanseri. DergiPark (Istanbul University). 21(2). 53–56. 3 indexed citations
20.
Sipahioğlu, Murat Hayri, Esra Sağlam, Oktay Oymak, et al.. (2005). Effect of Cyclosporine A on Total Homocysteine Level in a Rabbit Model. Transplantation Proceedings. 37(5). 2371–2374. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026